About Numiera Therapeutics Numiera is a preclinical-stage pharmaceutical company focused on developing small-molecule therapies for oncology indications. We are committed…
BOSTON, MASSACHUSETTS, Jan. 10, 2025 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing…